Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII

Thrombosis and Haemostasis

Volumn 94, Issue 6, 2005, Pages 1177-1180

  Schulman, Sam ^a,d   Tjønnfjord, Geir E ^b   Wallensten, Richard ^a   Martinowitz, Uri ^c   Kenet, Gili ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c SHEBA MEDICAL CENTER   (Israel)

^d Thrombosis Service   (Canada)

Author keywords

Bleeding; Factor VII deficiency; Recombinant factor VIIa; Surgery

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEMOPHILIA; HUMAN; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUPERFICIAL THROMBOPHLEBITIS; SURGICAL TECHNIQUE; THROMBOEMBOLISM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FACTOR VII DEFICIENCY; FACTOR VIIA; FEMALE; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SURGICAL PROCEDURES, OPERATIVE;

EID: 29244438433     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-05-0342     Document Type: Article

References (20)

1. Hedner U, Glazer S, Pingel K et al. Successful use of recombinant factor VIIa in a patient with severe haemophilia A during synovectomy. Lancet 1988; 2: 1193.
2. Bauer K. Treatment of factor VII deficiency with recombinant factor VIIa. Haemostasis 1996; 26 (Suppl 1): 155-8.
3. Ingerslev J, Knudsen L, Hvid I et al. Use of recombinant factor VIIa in factor-VII-deficient patients. Haemophilia 1997; 3: 215-8.
4. Jiménez-Yuste V, Villar A, Morado M et al. Continuous infusion of recombinant activated factor VII during caesarian section delivery in a patient withcongenital factor VII deficiency. Haemophilia 2000; 6: 588-90.
5. Hedner U. Dosing with recombinant factor VIIa based on current evidence. Semin Hematol 2004; 41(Suppl 1): 35-9.
6. Wong WY, Huang WC, Miller R et al. Clinical efficacy and recovery levels of recombinant FVIIa (Novo-Seven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency. Haemophilia 2000; 6: 50-4.
7. White B, O'Connor H, Smith OP. Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency. Blood Coagul Fibrinolysis 2000; 11: 155-7.
8. Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia 1999; 5: 253-9.
9. Schulman S, Bech Jensen M, Varon D et al. Feasibility of using recombinant factor VIIa in continuous infusion. Thromb Haemost 1996; 75: 432-6.
10. Schulman S, the rFVIIa-CI group. Safety, efficacy and lessons from continuous infusion with rFVIIa. Haemophilia 1998; 4: 564-7.
11. Schulman S, Johnsson H, Lindmarker P. Thrombotic complications after substitution with a FVII concentrate. Thromb Haemost 1991; 66: 619 (Letter).
12. Mariani G, Herrmann FH, Schulman S et al. International Factor VII Deficiency Study Group. Thrombosis in inherited factor VII deficiency. J Thromb Haemost 2003; 1: 2153-8.
13. Mazoyer E, Kevorkian J-P, Biyick E et al. Efficacy and safety of continuous infusion of factor VII concentrate in a factor VII-deficient patient at high risk for arterial thrombosis. Blood Coagul Fibrinolysis 2004; 15: 519-20.
14. Eikenboom JC, Bos CF, Briët E. Peri-operative replacement therapy with factor VII concentrate in a patient with severe factor VII deficiency. Thromb Haemost 1992; 67: 285-6.
15. Schulman S. Continuous infusion. Haemophilia 2003; 9: 368-75.
16. Brummel Ziedins K, Rivard GE, Pouliot RL et al. Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2004; 2: 1735-44.
17. Gershwin ME, Gude JK. Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency. N Engl J Med 1973; 288: 141-2.
18. Nakagawa K, Furusawa A, Momono S et al. Gastrectomy in a patient with congenital factor VII deficiency - a case report. Nippon Ganka Gakkai Zasshi 1990; 91: 771-3.
19. Aledort LM. Comparative thrombosic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. J Thromb Haemost 2004; 2: 1700-8.
20. Abshire T, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost 2004; 2: 899-909.